Jefferies Group LLC Curis Inc Put Options Transaction History

Jefferies Group LLC

3 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q2 2021 Aug 16, 2021	SELL	$7.45 - $16.27 $1.09 Million - $2.38 Million	-146,400 Closed	0 $0
Q1 2021 Sep 21, 2023	BUY	$8.78 - $12.8 $1.29 Million - $1.87 Million	146,400 New	146,400 $1.66 Million
Q1 2021 May 14, 2021	BUY	$8.78 - $12.8 $1.29 Million - $1.87 Million	146,400 New	146,400 $1.66 Million

Ticker CRIS
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 91,814,704
Market Cap $393M
Description
Curis, Inc., a biotechnology company, engages in the discovery and development of drug candidates for the treatment of human cancers in the United States. Its clinical stage drug candidates include Emavusertib, an oral small molecule drug candidate, which is in a Phase 1/2 clinical trial for the treatment of non-hodgkin lymphomas, and acute myel...

Get notified when there are updates to the investment portfolio of Jefferies Group LLC, based on Form 13F filings with the SEC.

Stay updated on Jefferies Group LLC with notifications on news.